Number of the records: 1  

New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity

  1. 1.
    SYSNO ASEP0561287
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleNew-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity
    Author(s) Talianova, V. (CZ)
    Kejik, Z. (CZ)
    Kaplánek, R. (CZ)
    Veselá, K. (CZ)
    Abramenko, N. (CZ)
    Lacina, L. (CZ)
    Strnadová, K. (CZ)
    Dvořánková, B. (CZ)
    Martásek, P. (CZ)
    Masarik, M. (CZ)
    Houdová Megová, M. (CZ)
    Bušek, P. (CZ)
    Křížová, J. (CZ)
    Zdražilová, L. (CZ)
    Hansíková, H. (CZ)
    Vlčák, Erik (UMG-J)
    Filimonenko, Vlada (UMG-J) RID, ORCID
    Šedo, A. (CZ)
    Smetana, K. (CZ)
    Jakubek, M. (CZ)
    Number of authors20
    Article number1712
    Source TitlePharmaceutics. - : MDPI
    Roč. 14, č. 8 (2022)
    Number of pages20 s.
    Publication formOnline - E
    Languageeng - English
    CountryCH - Switzerland
    KeywordsIL-6R synthetic inhibitors ; mitochondria ; cancer
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryPharmacology and pharmacy
    R&D ProjectsEF16_019/0000785 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2018129 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF18_046/0016045 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF16_013/0001775 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Research InfrastructureEATRIS-CZ III - 90133 - Univerzita Palackého v Olomouci
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000845735400001
    DOI10.3390/pharmaceutics14081712
    AnnotationIL-6 signaling is involved in the pathogenesis of a number of serious diseases, including chronic inflammation and cancer. Targeting of IL-6 receptor (IL-6R) by small molecules is therefore an intensively studied strategy in cancer treatment. We describe the design, synthesis, and characteristics of two new bis-pentamethinium salts 5 and 6 (meta and para) bearing indole moieties. Molecular docking studies showed that both compounds have the potential to bind IL-6R (free energy of binding9.5 and8.1 kcal/mol). The interaction with IL-6R was confirmed using microscale thermophoresis analyses, which revealed that both compounds had strong affinity for the IL-6R (experimentally determined dissociation constants 26.5 +/- 2.5 nM and 304 +/- 27.6 nM, respectively). In addition, both compounds were cytotoxic for a broad spectrum of cancer cell lines in micromolar concentrations, most likely due to their accumulation in mitochondria and inhibition of mitochondrial respiration. In summary, the structure motif of bis-pentamethinium salts represents a promising starting point for the design of novel multitargeting compounds with the potential to inhibit IL-6 signaling and simultaneously target mitochondrial metabolism in cancer cells.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2023
    Electronic addresshttps://www.mdpi.com/1999-4923/14/8/1712
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.